Market Access News | pharmaphorum

News

AbbVie files continuous Parkinson's therapy ABBV-951 in US

AbbVie has filed for approval of its therapy for Parkinson's disease, ABBV-951, which promises continuous control of symptoms and would be an alternative to current drugs that often fail to

News

Dupixent claims new territory in eosinophilic oesophagitis

Sanofi and Regeneron have added another string to the bow of their immunology blockbuster Dupixent with an FDA approval in eosinophilic oesophagitis (EoE), which could help the drug reach i

News

Sleepio app for insomnia backed by NICE

After a non-committal appraisal of Big Health's Sleepio app for insomnia last November in draft guidance from NICE, the cost-effectiveness agency has come out in favour of the digital thera

News

Coalition aims to improve cancer drug access in poorer natio...

Several of the top pharmaceutical companies have joined a new coalition that aims to improve access to cancer medicines in low- and lower-middle-income countries (LLMICs).

News

NICE endorses Magtrace diagnostic to detect breast cancer sp...

Women with breast cancer in England and Wales will soon be able to access a new diagnostic based on an injectable magnetic marker liquid called Magtrace that will identify if the disease ha

News

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approva...

Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to help keep their glucose levels in check.

AbbVie files continuous Parkinson's therapy ABBV-951 in US

Dupixent claims new territory in eosinophilic oesophagitis

Sleepio app for insomnia backed by NICE

Coalition aims to improve cancer drug access in poorer natio...

NICE endorses Magtrace diagnostic to detect breast cancer sp...

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approva...

Third Rock in $2bn drug-hunting pact with China's Funnel

Securing your ROI: Turning post-acquisition integration into...

News

Editor's Picks